Armata Pharmaceuticals (ARMP) Debt to Equity (2018 - 2026)
Quarterly results put Debt to Equity at -$0.28 for Q1 2026, up 45.17% from a year ago — trailing twelve months through Mar 2026 was -$0.28 (up 45.17% YoY), and the annual figure for FY2025 was -$0.47, changed 0.45%.
Armata Pharmaceuticals has reported Debt to Equity over the past 7 years, most recently at -$0.28 for Q1 2026.
- Debt to Equity reached -$0.28 in Q1 2026 per ARMP's latest filing, up from -$0.47 in the prior quarter.
- Across five years, Debt to Equity topped out at -$0.28 in Q1 2026 and bottomed at -$1.89 in Q1 2024.
- Median Debt to Equity over the past 4 years was -$0.66 (2025), compared with a mean of -$0.83.
- Peak annual rise in Debt to Equity hit 72.81% in 2025, while the deepest fall reached 0.45% in 2025.
- Over 4 years, Debt to Equity stood at -$0.74 in 2023, then soared by 36.43% to -$0.47 in 2024, then fell by 0.45% to -$0.47 in 2025, then skyrocketed by 40.11% to -$0.28 in 2026.
- Business Quant data shows Debt to Equity for ARMP at -$0.28 in Q1 2026, -$0.47 in Q4 2025, and -$0.66 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.06 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Dec 31, 2025 | -0.47 |
| Sep 30, 2025 | -0.66 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.51 |
| Dec 31, 2024 | -0.47 |
| Sep 30, 2024 | -0.81 |
| Jun 30, 2024 | -1.05 |
| Mar 31, 2024 | -1.89 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | -1.80 |
| Dec 31, 2020 | 0.10 |
| Sep 30, 2020 | 0.07 |
| Jun 30, 2020 | 0.05 |
| Mar 31, 2020 | 0.04 |
| Dec 31, 2019 | 0.07 |
| Sep 30, 2019 | 0.05 |
| Jun 30, 2019 | 0.03 |
| Dec 31, 2018 | 0.13 |